Erectile Dysfunction Completed Phase 3 Trials for Tadalafil (DB00820)

Also known as: EDS / ED / Erectile difficulties / Erectile Dysfunction (ED) / Difficulty maintaining an erection / Decreased erections / Male Erectile Disorder / Male Erectile Dysfunction / Difficult erection / Inability to achieve or maintain erection / Erectile Dysfunctions / Male erectile dysfunction, unspecified / Erectile dysfunction (disorder) / Impotence / Erectile dysfunction NOS / Impotent / Erectile disturbance / Erection failure / Psychogenic impotence

IndicationStatusPhase
DBCOND0029956 (Erectile Dysfunction)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04984993Clinical Investigation Using MED3000 Gel or Tadalafil Tablets in the Treatment of Erectile DysfunctionTreatment
NCT01937871A Study of Tadalafil in Men With Benign Prostatic Hyperplasia (BPH) and Erectile Dysfunction (ED)Treatment
NCT00855582A Study in the Treatment of Erectile Dysfunction and Benign Prostate HyperplasiaTreatment
NCT00836693Effect of Tadalafil Once a Day in Men With Erectile DysfunctionTreatment
NCT00734604A Study for Patients With Erectile Dysfunction to Test Whether Tadalafil Taken Once a Day Can Better Improve Psychological Outcomes.Treatment
NCT00668109Assessment of Efficacy of Vardenafil in Subjects With Erectile Dysfunction and Diabetes, Hypertension or HyperlipidemiaTreatment
NCT00421083Efficacy and Safety of Tadalafil in Subjects With Erectile Dysfunction Caused by Spinal Cord InjuryTreatment
NCT00381732A Study to Evaluate the Efficacy and Safety of 2.5mg and 5mg Tadalafil Given Once a Day to Men With Erectile DysfunctionTreatment
NCT00122499A Study to Assess the Efficacy of Tadalafil to Treat Erectile Dysfunction After Radiotherapy of Prostate CancerTreatment